SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Cardiovascular Systems, Inc. (CSII) and Lead Plaintiff Deadline: April 12, 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Cardiovascular Systems, Inc. (CSII) and Lead Plaintiff Deadline: April 12, 2016
PR Newswire
NEW YORK, Feb. 16, 2016
NEW YORK, Feb. 16, 2016 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, notifies investors of class action against Cardiovascular Systems, Inc. ("Cardiovascular Systems" or the "Company") (NASDAQ: CSII). The class action has been filed on behalf of a class consisting of all persons or entities who purchased Cardiovascular Systems, Inc. securities during the period between September 12, 2011 and January 21, 2016 inclusive (the "Class Period").
This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act").
Cardiovascular Systems, Inc. is a company devoted to developing and commercializing innovative solutions for treating peripheral and coronary vascular disease.
The Complaint alleges that throughout the Class Period, Defendants issued materially false and misleading statements to investors and/or failed to disclose that: (1) Cardiovascular Systems distributed illegal kickbacks to healthcare providers; (2) Cardiovascular Systems engaged in off-label promotion of its medical devices; and (3) Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices. As a result of this, Cardiovascular Systems' public statements were materially false and misleading at relevant times. Following this information entering the market, investors suffered damages.
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint and join the action, visit the firm's website: http://www.bgandg.com/#!csii/pz0v2. To discuss this action, or have any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email [email protected]. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Cardiovascular Systems you have until April 12, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-notifies-investors-of-class-action-against-cardiovascular-systems-inc-csii-and-lead-plaintiff-deadline-april-12-2016-300220671.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.